STA Pharmaceutical, a subsidiary of WuXi AppTec, said its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European Medical Products Agency (MPA). The new facility was opened at the end of 2018.   In 2017, WuXi STA merged with WuXi AppTec’s pharmaceutical development services unit. Two new commercial drug product facilities in Shanghai and Wuxi City have come into operation, enabling WuXi STA to support solid dosage d...